Jean Jacques Bienaime - Feb 7, 2023 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Feb 7, 2023
Transactions value $
-$882,540
Form type
4
Date filed
2/14/2023, 07:00 PM
Previous filing
Jan 18, 2023
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Gift $0 -200 -0.08% $0.00 247K Feb 7, 2023 Shares held by Jean-Jacques Bienaime Family Trust F2
transaction BMRN Common Stock Gift $0 +100 $0.00 100 Feb 7, 2023 Shares held as UTMA custodian for child F2
transaction BMRN Common Stock Gift $0 +100 $0.00 100 Feb 7, 2023 Shares held as UTMA custodian for child F2
transaction BMRN Common Stock Options Exercise $1.02M +15K +4.68% $67.81 335K Feb 10, 2023 Direct F3
transaction BMRN Common Stock Sale -$1.65M -15K -4.47% $110.11 320K Feb 10, 2023 Direct F3
transaction BMRN Common Stock Options Exercise $407K +6K +1.87% $67.81 326K Feb 13, 2023 Direct F3
transaction BMRN Common Stock Sale -$655K -6K -1.84% $109.15 320K Feb 13, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -15K -7.77% $0.00 178K Feb 10, 2023 Common Stock 15K $67.81 Direct F1, F3
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -6K -3.37% $0.00 172K Feb 10, 2023 Common Stock 6K $67.81 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.
F2 This transaction involved a gift of securities by the reporting person to his child under the Uniform Transfers to Minors Act.
F3 Trade made pursuant to a 10b5-1 plan executed on May 3, 2022.